Cysview: Who It’s For

Anyone who is suspected of having or is known to have bladder cancer (from a previous cystoscopy) can have BLC with Cysview.

Ideally, it should be used in :

  • first Transurethral Resection of Bladder Tumor (TURBT)
  • first follow-up cystoscopy
  • the management of intermediate-risk patients
  • the management of high-risk patients

For use in first TURBT and the management of intermediate and high-risk patients1

Recommended patient types2

  • Patients receiving first TURBT because of suspicion of non-muscle invasive bladder cancer (NMIBC)
  • Patients who received BCG treatment should have BLC with Cysview in their follow-up cystoscopy
  • Patients with multiple low-grade tumors
  • Patients with recurrent bladder tumors
  • Patients being re-evaluated post initial TURBT
  • Patients with positive cytology and negative white light cystoscopy

1 Cysview® [prescribing Information]. Photocure Inc. Princeton, NJ; 2018.
2 Daneshmand S, Schuckman A, Bochner B, et al. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: Review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct:11(10):589-96.